Merger Announced

Fulcrum Therapeutics and Slate Medicines merger

Announced 17 Aug 2026

Advisers

Slate Medicines

Target

Financial adviser
Legal adviser

Fulcrum Therapeutics

Acquirer

Financial adviser
Legal adviser

Other advisers

Target
Slate Medicines
Acquirer
Fulcrum Therapeutics
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.